课题基金 / 基金详情

Clostridium difficile: assessing the risks to Australia of an emerging healthcare-related pathogen

Clostridium difficile: assessing the risks to Australia of an emerging healthcare-related pathogen
艰难梭菌:评估一种新兴的医疗保健相关病原体对澳大利亚的风险
批准号:
nhmrc : 1006243
负责人:
Prof Archie Clements
金额:
$78.7万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2011
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2011-01-01 至 2015-12-31

项目摘要

项目成果

Prof Archie Clements的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Clostridium difficile is a bacterium that causes inflammation of the large bowel that can lead to surgical removal of the bowel or death. In North America and Europe, an international epidemic strain has caused large outbreaks of severe, fatal disease. In 2009, this strain was identified for the first time in Perth, Australia. We will investigate strains currently present in Brisbane and Perth and risk of outbreaks occurring from imported and local strains.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Spatiotemporal Risk Assessment of Emerging Infectious Disease Threats to Australia
  • 批准号:
    nhmrc : 1058878
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $42.76万
  • 财政年份:
    2014
  • 负责人:
    Prof Archie Clements
  • 依托单位:
Mapping and modelling of emerging infectious diseases in Australia
  • 批准号:
    nhmrc : GNT1058878
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $40.1万
  • 财政年份:
    2014
  • 负责人:
    Prof Archie Clements
  • 依托单位:
Spatial risk assessment of emerging infectious diseases in Australia
  • 批准号:
    nhmrc : 631619
  • 项目类别:
    Career Development Fellowships
  • 资助金额:
    $23.07万
  • 财政年份:
    2010
  • 负责人:
    Prof Archie Clements
  • 依托单位:
国内基金
海外基金
肠道菌群介导的脱氧胆酸激活S1PR2/NLRP3/IL-1β通路在炎症性肠病合并艰难梭菌感染中的致病机制研究
  • 批准号:
    82372306
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    彭奕冰
  • 依托单位:
自噬通路在艰难梭菌毒素杀伤宿主细胞过程中的作用探究
  • 批准号:
    31170126
  • 项目类别:
    面上项目
  • 资助金额:
    55.0万元
  • 批准年份:
    2011
  • 负责人:
    魏文胜
  • 依托单位: